Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(5 sites)
Canada
BC Cancer Agency, Vancouver, British Columbia QEII Health Sciences Centre, Halifax, Nova Scotia Princess Margaret Cancer Centre, Toronto, Ontario Sunnybrook Research Institute, Toronto, Ontario Centre Hospitalier Universitaire de Québec, Québec, Quebec Last updated February 2025